 Ridinilazole

Ridinilazole (INN, previously known as SMT19969) is a non-absorbable small molecule antibiotic for oral administration to treat "Clostridioides difficile" infection (CDI).The Centers for Disease Control and Prevention (CDC) estimates 500,000 cases of CDI per year and on average 29,000 deaths per year attributed to CDI in the United States (USA).